Symbol="SNDX"
AssetType="Common Stock"
Name="Syndax Pharmaceuticals Inc"
Description="Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. The company is headquartered in Waltham, Massachusetts."
CIK="1395937"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3, WALTHAM, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1275947000"
EBITDA="-172851008"
PERatio="None"
PEGRatio="0"
BookValue="5.76"
DividendPerShare="0"
DividendYield="0"
EPS="-2.46"
RevenuePerShareTTM="2.173"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.258"
ReturnOnEquityTTM="-0.421"
RevenueTTM="126576000"
GrossProfitTTM="139709000"
DilutedEPSTTM="-2.46"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="332.97"
AnalystTargetPrice="37.13"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="12.67"
PriceToBookRatio="4.872"
EVToRevenue="10.25"
EVToEBITDA="-119.95"
Beta="1.121"
num_52WeekHigh="29.86"
num_52WeekLow="17.88"
num_50DayMovingAverage="20.79"
num_200DayMovingAverage="22.58"
SharesOutstanding="68821000"
DividendDate="None"
ExDividendDate="None"
symbol="SNDX"
open="18.23"
high="18.63"
low="18.21"
price="18.54"
volume="406711.00"
latest_trading_day="2023-08-11"
previous_close="18.37"
change="0.17"
change_percent="0.9254%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="66"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="34"
Volume_recent_avg="866780"
Change_recent_avg="-0.12"
Delta_recent_avg="0.88"
Variance_recent_avg="0.44"
Change_ratio_recent_avg="-0.59"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="34"
Aroon_momentum_negative="66"
image_negative_thumbnail_id_1="1130"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0163.jpeg"
image_negative_thumbnail_id_2="1105"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0138.jpeg"
image_neutral_thumbnail_id_1="553"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_neutral_thumbnail_id_2="564"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_positive_thumbnail_id_1="691"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0017.jpeg"
image_positive_thumbnail_id_2="618"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1200"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
